Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
出版年份 2022 全文链接
标题
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
作者
关键词
-
出版物
Frontiers in Public Health
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-03-02
DOI
10.3389/fpubh.2022.809675
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A dangerous measles future looms beyond the COVID-19 pandemic
- (2021) David N. Durrheim et al. NATURE MEDICINE
- Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the NanopatchTM Microneedle Delivery System
- (2021) Ying Wan et al. Human Vaccines & Immunotherapeutics
- A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy
- (2021) Debra Kristensen et al. VACCINE
- Feasibility assessment of measles and rubella eradication
- (2021) William J. Moss et al. VACCINE
- Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30
- (2020) So Yoon Sim et al. HEALTH AFFAIRS
- Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
- (2020) Kaja Abbas et al. Lancet Global Health
- Potential use of microarray patches for vaccine delivery in low- and middle- income countries
- (2019) Nicolas Peyraud et al. VACCINE
- A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques
- (2018) Jessica C Joyce et al. JOURNAL OF INFECTIOUS DISEASES
- Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™)
- (2018) Germain J.P. Fernando et al. VACCINE
- The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial
- (2017) Nadine G Rouphael et al. LANCET
- Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children
- (2017) Carlos Wong et al. PLoS One
- Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development
- (2016) Bishwa B. Adhikari et al. Drugs in research & development
- Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
- (2016) Theone C. Kon et al. PLoS One
- An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine
- (2015) Bruce Y. Lee et al. VACCINE
- Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies
- (2014) Ozan S. Kumru et al. BIOLOGICALS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started